It is becoming more apparent each day that despite a strong national commitment to excellence in health care, the resources and personnel are finite. It is, therefore, appropriate that the medical profession examine the impact of developing technology on the practice and cost of medical care. Such analysis, carefully conducted, could potentially have an impact on the cost of medical care without diminishing the effectiveness of that care.
Preamble
It is becoming more apparent each day that despite a strong national commitment to excellence in health care, the resources and personnel are finite. It Garrett and colleagues' and Favaloro and colleagues2 in 1969, the coronary artery bypass graft operation has become the most completely studied operation in the history of surgery. It has been shown to be highly effective in the relief of severe angina and under some circumstances has the capability for considerably prolonging useful life. Nonetheless, outcome after the operation and its place in the overall management of patients with ischemic heart disease has not been easily defined because of 1) the multifactorial nature and inherent complexities of ischemic heart disease, 2) the multitude of treatment options that have become available, 3) the variability in the performance of the technical details of the operation and of the myocardial management, and 4) the variability in the methods of evaluating outcome after the operation and comparing it with that after other treatments. Even the minimal resources required to obtain good results have remained arguable, although this issue has been addressed on numerous occasions by governmental and nongovernmental groups since the report by the Inter-Society Commission for Heart Disease Resources in 1972. 3 Because of the considerable personnel and facility requirements of the coronary artery bypass graft operation and the frequency with which it is indicated for a disease of high prevalence, the monetary costs of the procedure have become large and of individual, local, and national concern. The reasons for these high costs have been addressed to some extent, but proposals for reducing them have dealt largely with costs, charges, and reimbursement rather than substantive suggestions for making the procedure itself less expensive.
The American College of Cardiology and the American Heart Association have designated a Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. That Task Force appointed a Subcommittee to develop guidelines and indications for the coronary artery bypass operation. This is the report of the Subcommittee. It contains a distillation of current information, focused on present indications and practices. A new edition of this report will surely be indicated within five years, as new information becomes available.
In this report, general information relating to the indications for the coronary artery bypass graft operation (Section VI) has been derived from comparison of the operation's benefits with those of initial medical treatment. Merely obtaining a consensus among (Table 1) . However, this Subcommittee emphasizes that these general indications cannot take into account even the majority of the variables that are involved in most recommendations to patients. The treatment classes can better be defined for individual patients from the patient-specific depictions of time-related comparative benefits of the coronary bypass operation relative to medical treatment (for details see Section X). The presence of percutaneous transluminal coronary angioplasty as a commonly used alternative form of interventional therapy is recognized, and the few comparisons that are possible have been made (Sections V and X). Recognizing the relative paucity of comparative information, the Subcommittee believed that this report needed to reflect some judgments as to the indications for the coronary bypass operation in an era when both medical treatment and coronary angioplasty are available. This was done in Section VI. More secure recommendations can be made in the future, when more information is available.
This entire report is intended to provide a framework that physicians can use in combination with other kinds of information and their best judgment as they offer recommendations to the patient, who in the last analysis makes the decision.
This Subcommittee expresses its appreciation for the constant support, advice, and counsel of Charles Fisch, MD, and Sylvan Lee Weinberg, MD, from the parent Task Force. It is grateful for the support and considerable operational assistance of David Feild and Michael Forcinito of the American College of Cardiology. It also thanks Debbie Nuby, Brooks Counts, and Nancy Ferguson for their enormous contributions to the preparation of the material for this report and of the final document itself.
II. The Coronary Artery Bypass Graft Operation
A. The Operation The coronary artery bypass graft operation consists of the construction of new pathways (conduits) between the aorta (or other major arteries) and seg- Hazard function for death in the same group ofpatients. Note 1) the early, rapidly declining phase, merging with the constant phase about 3 months after the coronary bypass operation, 2) the constant phase, and 3) the slowly rising third phase of hazard, beginning about 5 years after the operation.
ments of coronary arteries beyond stenosing or obstructing lesions for the purpose of bringing blood to myocardium made ischemic by these lesions. Cardiopulmonary bypass with a pump oxygenator is used for nearly all coronary bypass graft operations. Thus, in addition to the surgeon, cardiac anesthesiologist, and surgical nurse, a competent perfusionist is required (see Section VIII).
Since the early years of the operation, reversed segments of autologous saphenous vein have been used as the conduit. Greater saphenous vein is expendable, generally available in sufficient length, appropriately sized to match the coronary arteries, capable of reaching beyond the stenoses of all diseased arteries, pliable enough to allow easy suturing, and is autologous. When a greater saphenous vein is not available, the lesser saphenous vein may be used. Saphenous veins are used as free grafts, anastomosed proximally to the ascending aorta and distally to one or more coronary arteries. Because increasing experience has documented the time-dependent diminution of patency in saphenous vein bypass grafts (see Section III), the left internal mammary artery (internal thoracic artery) is now widely used, particularly for revascularization of the left anterior descending coronary artery system. The internal mammary artery, left attached to its origin from the left subclavian artery, is mobilized from the chest wall and anastomosed to the left anterior descending artery. The right internal mammary artery can often be used in a similar fashion. About 95% of internal mammary arteries used in this way by experienced surgeons are patent 10 years after the coronary bypass operation4 (see Appendix, Figure A1 ), and failure to use the internal mammary artery in this manner has been demonstrated to be a risk factor for premature late death after the operation (see Appendix, Figure   A2 ). [4] [5] [6] The use of the left or right internal mammary artery as a free graft from the ascending aorta to the left anterior descending artery provides almost comparable results.7 Currently available information indicates that the internal mammary artery should be used almost routinely for revascularizing the left anterior descending artery system in the coronary bypass operation.
Use of bilateral internal mammary artery grafting has become popular, but as yet the available evidence does not support the hypothesis that long-term survival is increased by its use,56,8 and the risk of sternal wound complications is increased by the double internal mammary artery procedure in obese or diabetic patients. 9 The patency advantage of the internal mammary artery when anastomosed to vessels other than the left anterior descending artery is uncertain.10 When neither internal mammary artery can be used, the right gastroepiploic artery, the inferior mesenteric artery, or the inferior epigastric artery may be used, although long-term advantages of these arteries over saphenous vein grafts have not been demonstrated. Segments of radial artery, arm veins, allograft arteries and veins, and synthetic tubes have been less satisfactory as conduits and should be used only as a last resort. Current information5,6 suggests that incomplete revascularization is a risk factor for premature death and other unfavorable outcome events after coronary bypass surgery. As a result, anastomoses have been made to vessels with a diameter as small as 1 mm with acceptable patency rates, and there has been more extensive use of sequential grafting, in which a conduit is anastomosed to two or three coronary arteries A a distally. It has been suggested5'6 that the use of sequential grafting predisposes to graft failure and thus is a risk factor for unfavorable events late postoperatively, but this remains arguable. Endarterectomy of the diseased coronary artery wall is occasionally utilized in combination with coronary artery bypass grafting and has yielded variable results. Intraoperative hemostasis should be obtained by meticulous surgical technique, in preference to extensive use of blood products. The use of autologous preoperative or intraoperative blood donation, ultrafiltration devices in the pump oxygenator system, collection of intraoperatively shed blood by devices that wash and concentrate the erythrocytes, and the reinfusion of shed blood drained from the chest tubes during the early postoperative hours minimize the amount of donor bank blood that must be used. In about 50% of patients undergoing primary coronary artery bypass grafting and without preoperative anemia, no homologous blood should be required. However, important bleeding tendencies develop in some patients and require specific therapy.
B. Myocardial Management
Patients with coronary artery disease are more susceptible to major and minor myocardial injury immediately preoperatively, during induction of anesthesia, and before cardiopulmonary bypass than are other patients, and precise management is necessary during these periods. Proper myocardial management therefore begins preoperatively, with optimization of the patient's antianginal drug regimen. In general, fl-receptor and calcium channel blocking therapy and intravenous nitroglycerin, if that is being administered, should be continued until the patient comes to the operating room. Particular attention to avoidance of myocardial ischemia is necessary during induction of anesthesia and in the period before cardiopulmonary bypass.
Methods of myocardial management during cardiopulmonary bypass are variable, probably because in uncomplicated cases good results are being obtained with all the methods that are commonly in use, and in complex and seriously ill patients few methods have been documented to result in less myocardial necrosis and better survival than any other. Most methods of myocardial management impose certain requirements on the sequencing and techniques of the coronary artery bypass operation, and changes from a successful method of myocardial management should not be made without the surgeon's consideration of the possible unfavorable effect of the combination of his or her particular technique of operation with a new method of myocardial management. The most important aspect of myocardial management is the continuous, thoughtful attention given to it by the surgeon and anesthesiologist throughout the operation.
One successfully used technique includes no periods of global myocardial ischemia during moderately hypothermic cardiopulmonary bypass. When this method is used, the operation may be facilitated and outcomes improved by continuous ventricular fibrillation.11 A second successfully used method is that of intermittent occlusion of the ascending aorta, often preceded by the administration of nifedipine, lidoflazine, or similar agents. 12, 13 A third technique that has given good results is the use of a single period of profoundly hypothermic global myocardial ischemia, achieved by profoundly cooling the heart before cross-clamping and maintained by irrigating the pericardial space with cold saline solution.14 A fourth and commonly used technique is cold cardioplegia and a single period of global myocardial ischemia15l16 with antegrade or retrograde infusion, or both, of a hyperkalemic solution. A fifth method that has given good results is cold sanguineous cardioplegia plus controlled initially hyperkalemic reperfusion and, under special circumstances, warm cardioplegic induction. This latter technique may have particular advantages when left ventricular function is chronically or acutely depressed preoperatively. [17] [18] [19] [20] After cardiopulmonary bypass, arterial hypotension or hypertension is avoided by appropriate management of blood volume and by drug therapy, and heart rate and rhythm are controlled, when necessary, by pacing with temporary epicardial atrial and ventricular pacing wires. Ventricular arrhythmias are minimized by appropriate myocardial management during the coronary artery bypass operation, but drug therapy may occasionally be necessary early postoperatively.
Infrequently in uncomplicated cases with good myocardial management, but more commonly in patients who come to the operating room with acute or chronic severe impairment of left ventricular function, a temporary assist device is required after cardiopulmonary bypass. In this circumstance, the intra-aortic balloon is used most commonly. Left ventricular and biventricular assist devices can be used when the balloon is ineffective, but the frequency of their need and their risk/benefit ratio when myocardial management has been optimal remain to be determined.
III. Status After the Coronary Bypass Operation (Outcome Events) The coronary artery bypass graft operation has a favorable effect on symptoms and useful life expectancy in many patients. However, it does not cure arteriosclerotic heart disease, and in most patients at some point, usually many years after operation, clinical evidence of myocardial ischemia returns and is followed by death, which in more than half the patients is related to recurrent myocardial ischemia. This section addresses the nature of the postcoronary artery bypass state by categorizing and describing the results of the operation in terms of the probability of freedom from unfavorable outcome events and the risk factors that work against optimal outcome.
The interval between coronary artery bypass surgery and the time of occurrence of unfavorable outcome events is highly variable and of great impor- tance to the patient and to society. Therefore, the results (the probability of freedom from an outcome event) are depicted in a time-related manner. This is accomplished by use of 1) the life table method (most commonly and advantageously that of Kaplan and Meier21), reinforced by multivariable estimates of relative risks by the Cox-Breslow method,22'23 or 2) a parametric method in the multivariable hazard function domain. 24 The multivariable analyses identify risk factors that independently affect outcomes and determine the strength of their effect. The analyses must be multivariable, parsimonious, and conducted with medical knowledge, because 1) the effects of risk factors are incremental, 2) some risk factors interact with others in specific ways, and 3) some characteristics that seem to be risk factors are surrogates for more fundamental risk factors. This is all necessary because patients with coronary artery disease requiring treatment have characteristics that may vary enormously from one patient to another. Many of these characteristics are prognostically important, whatever the form of treatment of the patient. Some patients have other important diseases that have an impact on outcome after coronary artery bypass surgery and other kinds of treatment, and thus on the indications for the various forms of therapy. The operation is complex (Section II) and can vary considerably among patients, surgeons, and institutions. It follows that the simple depiction of the time-related freedom from an untoward event in a heterogeneous group of patients is of limited value in understanding the nature of the postcoronary bypass state, the appropriateness and effectiveness of the bypass operation in comparison with alternative methods, and the probable outcome in a specific patient coming for treatment of ischemic heart disease.
A. Survival (Freedom From Death) Death from any cause is a secure end point with which to judge the efficacy of coronary artery bypass surgery and to compare it with alternative forms of therapy. In general, about 96.5% of heterogeneous groups of patients survive at least 1 month after the operation, and 95%, 88%, 75%, and 60%, respectively, survive 1, 5, 10, or >15 years after the operation ( Table 2 ). The time-related survival and the hazard function are shown in Figure 1 . (The hazard function depicts the instantaneous risk of an event, such as death, at each moment in time after the starting point in time [time zero], which here is the time of the bypass operation. It may be thought of as the rate at which that event is occurring at each point in time after time zero. The percent of patients free from the event [here the percent survival] at any point in time after time zero represents the accumulation of all the hazard functions, or rates, up to that point.)
The prevalence of risk factors in a group of patients and the degree to which they are present in individual patients decrease or increase the probability of death after coronary artery bypass surgery. The risk factors for death after the coronary bypass operation are shown in Table 3 , and most of the preoperative risk factors are also risk factors for death in patients with arteriosclerotic coronary artery disease managed by any method. The risk factors for other unfavorable outcomes after the bypass operation are similar to these, although not identical. Many risk factors are specific to the early period after operation; others have their effect late postoperatively.
Patients may live comfortably and productively after coronary artery bypass surgery, or they may have other interval events and may undergo repeat bypass surgery, coronary angioplasty, or even cardiac transplantation.
B. Modes of Death
The precise cause of death can uncommonly be assigned, and this is particularly true in the complex situation of ischemic heart disease. Modes of death can be assigned with reasonable reproducibility. Cardiac death is the most prevalent mode (Table 4) . Studies using cardiac death (rather than all deaths) as an end point after the coronary artery bypass operation have demonstrated that 1) the probability of cardiac death early postoperatively is less after operations performed in the recent era than in earlier years, 2) the more severe and extensive the coronary artery disease, the greater is the comparative benefit of the operation over medical treatment, and the less severe and extensive the disease, the less the comparative benefit, and 3) the more severe the left ventricular dysfunction, the greater the comparative benefit of the operation35 (see Appendix, Figures Bi and B2 ). The risk factors and inferences when using cardiac death as the end point are similar to those derived when all deaths are used as the end point, and the two kinds of analyses reinforce each other. tCardiac failure (which could be termed cardiac death) is considered acute when it occurs within 3 days of an operation or a new myocardial infarction, subacute when it occurs between 3 days and 6 weeks of such events, and chronic when it is not preceded by an identified proximal previous event.
C. Return ofAngina
The evidence, both symptomatic and from graded exercise testing, is complete that the coronary artery bypass operation relieves angina in most patients. However, the return of angina is the most prevalent of the postoperative ischemic events (Figure 2 ). The hazard function for return of angina begins to rise after about 5 years (Appendix, Figure B3 ). The return of angina very early after coronary bypass surgery, typically recognized with resumption of activity, usually is due to incomplete revascularization or early closure of grafts. Angina occurring later usually is a reflection of narrowing or closure of one or more grafts or progression of native vessel disease, or both.
The risk factors for the return of angina are similar but not identical to those for death (see Appendix B). Nonuse of the internal mammary artery is not a risk factor (Appendix, Figure B4 ), and this observation suggests that survival depends in a major way on a continuing blood supply to the left anterior descending artery with its septal branches, while angina may return as a result of recurrent or new ischemia in the distribution of the right or circumflex coronary systems without necessarily predicting death. FIGURE 2. Time-related probability of freedom from the first return of angina after the coronary artery bypass operation in the same heterogeneous group of patients referred to in Figure 1 Sudden cardiac death is uncommon in general after the bypass operation (see Table 4 ). By 10 years after undergoing the operation, 95% of patients are free of sudden death, as are about 90% by 15 years.39 F. Heart Failure Only 5% to 10% of deaths after the coronary bypass operation occur in patients with the syndrome of chronic heart failure (see Table 4 ). In part, this is because patients with ischemic heart disease and important chronic heart failure usually have severe left ventricular dysfunction as a result of extensive myocardial scarring and are not advised to undergo bypass surgery (see Section VI).
G. Unsatisfactory Quality of Life
It is nearly impossible to quantify an unsatisfactory quality of life after the coronary bypass operation, even though it is one of the most important unfavorable outcome events. This relates in part to the fact that an unsatisfactory quality of life is a composite of at least freedom from limiting angina or heart failure, the preservation of a reasonable exercise capacity, and reasonable freedom from the need for medication, rehospitalization, and reintervention. Most surviving patients have a satisfactory quality of life early after the bypass operation, but the probability of retaining this quality begins gradually to decline after about 5 years.40 The rate of decline in the quality of life is probably similar to that of the freedom from angina (see Figure 2) .
As in all other outcome events, the probability of freedom from an unsatisfactory quality of life in an overall heterogeneous group is of limited value when considering individual patients. The Unrelated to the cardiac aspects of the coronary bypass operation, the damaging effects of the cardiopulmonary bypass usually required for the operation result in neurobehavioral disturbances in some patients. These are sufficiently mild that they may not be apparent unless patients are tested specifically for them, and their prevalence has been somewhat reduced recently by the incorporation of appropriate filters in the arterial line from the pump oxygenator to the patient. As many as 75% of patients exhibit these subtle defects when tested 8 days after operation, but by 3 months postoperatively only about 10% to 30% exhibit them.49,50 The prevalence is unfavorably affected by postoperative anxiety and depression and by older age.51 Only rarely are patients aware of or handicapped by these defects. 52 Gross neurologic defects, usually in the form of transient or permanent sequelae of strokes, are more serious but fortunately are considerably less common. They are more likely to result from embolization of atherosclerotic debris from the ascending aorta or from air embolization than from the damaging effects of cardiopulmonary bypass. The prevalence is about 0.5% in relatively young patients but rises to about 5% in patients >70 years of age and to about 8% in those >75 years.53.54
J. Graft Disease and Patency
The highest patency rates for coronary bypass grafts are associated with use of the left internal mammary (thoracic) artery to bypass important proximal stenoses of the left anterior descending coronary artery. These patency rates are approximately 95% at 10 years after operation,4 and closure of the mammary artery after that time is uncommon. Few factors appear to affect the patency rate of the internal mammary artery when anastomosed to the anterior descending artery. This favorable performance of the internal mammary artery when anastomosed to the left anterior descending coronary artery is probably due to its particular wall structure and function and the potentially large runoff through the left anterior descending artery system. Internal mammary artery grafts to other vessels appear to have lower patency rates late postoperatively than do those to the left anterior descending artery, and these may be no greater than those of vein grafts. 10 The patency rates of the other arterial conduits currently in use (see Section II) have not as yet been reliably determined.
Saphenous The 10-year patency rate of vein grafts appears to be highly variable, and in some reports5758 only 50% to 60% overall are still patent. Other reports4 indicate that the patency rate of vein grafts depends in part on the coronary artery to which they are anastomosed, with about 80% of those to the left anterior descending artery being patent at 10 years, and only 70% to 75% of those to other vessels. The mean yearly attrition rate of vein grafts after 10 years is about 5% * year-1.57,59 Arm veins have a still lower prevalence of patency,60 as do synthetic conduits.
Lesser distal runoff, determining as it does the flow through the graft, reduces saphenous vein graft patency rates. Therefore, patency rates are lower when the anastomosis is to small coronary arteries and to arteries supplying areas with considerable scar. Whether the placement of two or more distal anastomoses on a vein graft (sequential grafting) increases or decreases patency rates is arguable.
Patency rates of saphenous vein grafts can be improved by the administration of antiplatelet drugs (see Section VII).
K Reintervention After Coronary Bypass Surgery
Reintervention, either a second bypass operation or coronary angioplasty, is sometimes indicated in the years after the first bypass operation, because of evidence of important recurrent myocardial ischemia. As would be expected, reintervention is uncommon within 5 years of the bypass operation but more frequent thereafter (PT Sergeant Comparisons of outcome after the coronary bypass operation with that after alternative forms of treatment are best done in terms of the time-related comparative benefit (appropriateness) of the bypass operation. 35 End points in such comparisons may be freedom from death (survival), from angina, from fatal or nonfatal myocardial infarction, from sudden death, or from the coronary bypass operation itself (a repeat bypass operation if the initial therapy was the bypass operation, otherwise the first bypass operation after some other form of initial therapy). Death is the most unequivocal of these, and the available information suggests that the time-related comparative benefit of the coronary bypass operation is at least as great when any of the other end points are used.
Therefore, and because of limitations of space, survival is the end point used for the comparisons in this section.
The methodology for making the comparisons used by the Subcommittee is presented in Appendix C.
The comparisons in this report refer to the initial coronary bypass operation in comparison with some other form of initial therapy. The "initial" refers to therapy at the time of decision making, whether it is the first or a subsequent episode of decision making. All analyses of outcome described in the report are by the so-called intention-to-treat principle, and patients are not deleted (censored) from the analyses if at some subsequent time a different treatment is used. 61 Unfortunately, there is no valid way to compute outcome after isolated medical treatment, coronary bypass surgery, or coronary angioplasty in an era in which later crossover after any form of initial therapy is not only allowed but is often good management. 61 The comparisons in this section are based on the known risk factors but of necessity address only a single risk factor at a time. As such, they are useful in providing background information, but comparisons in this format are of limited value in decision making for individual patients, because all of the patientspecific risk factors together, not just one alone, determine outcome in individual patients. Thus, the patient-specific comparisons for individual patients, discussed in Section X, should be more useful as an aid to decision making.
A. Comparison According to Severity ofAngina
In general, the more severe the angina, the less favorable the outcome after initial medical therapy, while outcome after the coronary artery bypass operation as initial therapy is relatively unaffected by the preoperative severity of angina3233 ( Figure 3 ). This relates to the fact that the severity of the angina is a surrogate (substitute) for the magnitude of the decrement in myocardial blood flow reserve, and this risk factor is neutralized by the coronary bypass operation when essentially complete revascularization is achieved. Thus, the benefit of initial surgical treatment, compared with that of initial medical treatment, is in general greater, the more severe is the angina.
B. Comparison According to Objective Evidence of Ischemia
The inferences concerning angina, a symptom of reversible myocardial ischemia, are reinforced by similar comparative benefits when the amount of reversible myocardial ischemia is examined by electrocardiographic (ECG), functional, or perfusion evidence of ischemia during graded exercise testing. The more severe the exercise-induced ischemia, the greater the comparative benefit of initial coronary bypass operation (see Appendix, Figure C1) dix, Figure C2 ).31 However, about 20% of patients initially given medical treatment are advised to have and actually undergo the coronary bypass operation Figure C3 ). In general, the greater the number of major coronary arteries with important stenoses, the less the time-related survival with initial medical treatment. Since the time-related survival after coronary bypass surgery is only weakly affected by the number of diseased vessels, the surgical benefit is greater, the greater the number of diseased vessels.33 '35 The greater the number of vessels with important proximal stenoses, the greater the comparative benefit of surgery, because survival after initial medical treatment declines as the number of proximal stenoses increases whereas that after coronary bypass surgery does not (see Appendix, Figure C4 ). 33 A proximal stenosis in the left anterior descending coronary artery appears particularly to increase the comparative surgical benefit25 (see Appendix, Figure C5 ).
E. Comparison According to Left Ventricular Function
In general, the more severe the left ventricular dysfunction, the greater the comparative benefit from surgery (see Appendix, Figure C6 ), even though the FIGURE 4. Nomogram of an equation, describing the comparative benefit (difference in percent freedom from cardiovascular death after two treatments) at some time (t) of the coronary artery bypass operation (or angioplasty) over medical treatment. This comparative benefit, along the vertical axis, is determined by the interrelation between 1) the percent (probability of) freedom from cardiovascular death at time (t) after the initiation of medical treatment, and 2) the number ofcoronary arteries whose stenoses have been completely neutralized by interventional therapy (indicated by the isobars). The values of the isobars are, in fact, the hazard ratios, and the hazard ratios represent the effect on comparative benefit of the number ofarteries with important stenosis inpatients undergoing a coronary bypass operation. The nomogram pertains when time (t) is be- early and late results of the coronary bypass operation are somewhat less good in patients with important left ventricular dysfunction than in those with essentially normal left ventricular function.33, 35 The comparative benefits of the coronary bypass operation are particularly great when associated risk factors such as extensive coronary artery disease and severe ischemia are also present. 36 Extreme left ventricular dysfunction is usually an indication of extensive left ventricular scarring, with little or no "reversible ischemia." Under these circumstances, the prognosis with both initial medical and initial surgical treatment is limited. However, the precise level of ejection fraction (or CASS score) that is indicative of lack of any substantial surgical benefit is not yet established but is probably less than 0.2 or even 0.15 (see more detailed discussion in Section VI).
Patients with important left ventricular dysfunction but truly without reversible ischemia do not benefit from the operation. F The foregoing has described briefly the available information concerning the advantages, when they exist, of the coronary artery bypass operation over medical treatment. A broader, conceptually useful view of the role of interventional therapy in patients with ischemic heart disease can be obtained from Figure 4 , adapted from the study by Califf et al. 35 Survival with medical treatment is dependent on the individual's patient-specific risk factors. (Survival, or more specifically, the freedom from cardiovascular death, is depicted along the horizontal axis of Figure  4 .) The comparative benefit of coronary artery bypass surgery, depicted along the vertical axis, is dependent on 1) the number (and type) of coronary arteries whose stenoses have been completely "neutralized" by the bypass operation (represented by the isobars) and 2) the survival with medical treatment. It follows that the potential comparative benefit from the bypass operation is limited by the number of vessels with important stenoses to be neutralized. A more subtle implication is that survival after the operation is the least good in patients anticipated to have poor survival with medical treatment, even though the comparative benefit is the greatest; conversely, the sur- There is a considerable comparative benefit (and no comparative benefit of coronary angioplasty) of an initial coronary bypass operation over initial medical treatment, and this is very unlikely to be due to chance alone. c) Predicted hazard functions. d) Hazard ratios. The hazard ratio for an initial coronary artery bypass operation compared with initial medical treatment is considerably <1, and the difference from 1 is very unlikely to be due to chance alone. vival rate is highest in patients anticipated to have good survival with medical treatment, even though the comparative benefit is the least in such patients.
Study of Figure 4 indicates that, conceptually, even patients with single vessel disease, neutralized by the coronary bypass operation, achieve some comparative benefit with respect to survival (assuming that the risk of the interventional procedure itself is negligible). However, when left ventricular function is good and all other risk factors indicate a high probability of survival with medical treatment (95% freedom, along the horizontal axis), the comparative benefit is small, probably not identifiable, and of insufficient magnitude to indicate an advantage for the bypass procedure. The benefit is greater in paients with two-and three-vessel disease. When left ventricular dysfunction is present and this and other risk factors move the patient to the left on the horizontal axis, the comparative benefits of one-, two-, and three-vessel disease become still larger and more easily identified.
Although these concepts were derived from an analysis in which the coronary bypass operation was the interventional therapy, they apply to coronary angioplasty as well. However, it must be remembered that the isobars in Figure 4 represent vessels whose stenoses have been completely neutralized by the intervention. When they are not, the figure does not apply.
V. Comparisons of the Coronary Bypass Graft
Operation With Coronary Angioplasty The paucity of proper risk-adjusted comparisons and the absence of comparisons from randomized trials, among 1) coronary artery bypass grafting, 2) percutaneous transluminal coronary angioplasty, and 3) medical treatment, is severely limiting to this report and to clinical practice. The results of the ongoing trials designed to compare these treatments will not be known for a considerable period of time. Yet, ignoring the effect of the existence of coronary angioplasty on the indications for the coronary bypass operation is unrealistic (see Section VI for further details). Therefore, the comparative information that exists is presented.
Coronary angioplasty offers, in general, a major comparative advantage over the coronary bypass A. Survival Nonrisk-adjusted comparisons of survival out to 5 years in heterogeneous groups of patients have shown no or small differences in this regard between initial coronary bypass surgery and initial coronary angioplasty69-73 (see Appendix, Figure Dl, which shows a small advantage of coronary angioplasty, not confirmed when risk-factor adjustment was made). Riskadjusted comparisons are few, but they suggest that most elderly patients with three-vessel coronary artery disease have a considerable comparative survival benefit from an initial coronary bypass operation over that obtained by initial coronary angioplasty (see Appendix, Figure D2 ); that some patients with two-vessel disease receive a considerable comparative benefit from the bypass operation relative to angioplasty; and that few patients with one-vessel disease have a comparative benefit from the bypass operation over angioplasty with respect to survival.73
B. Freedom From Recurrence ofAngina
Most comparative studies indicate that the duration of freedom from angina is less after initial coronary angioplasty than after initial coronary bypass surgery69,71-75 (see Appendix, Figure D3 ), although in one of the studies with a follow-up of about 2 The coronary artery bypass operation is indicated for the relief of symptoms (primarily angina) that are unresponsive to medical treatment (or to coronary angioplasty), particularly when the duration of freedom from unfavorable events (death, myocardial infarction, return of angina) can with reasonable confidence be predicted to be appreciably longer than with other forms of treatment. The indications as discussed in this section are general, and derived, inasmuch as possible, from information about freedom from death (survival) and from other unfavorable outcome events after the coronary bypass operation (see Section III), and about the comparative benefit, positive or negative, of this operation compared with medical treatment (Section IV). However, a general discussion of indications must of necessity be an oversimplification as it can be based on only a few general risk factors. This has led to some differences of opinion about the treatment classes for the tables. Differences of opinion among experts would undoubtedly be very much less in individual patients in whom patient-specific predictions and comparisons had been made (see Section X).
Although only a relatively small amount of pertinent, comparative information is available about outcomes after coronary angioplasty (Sections V and X), the experience with the technique and the prevalence of its use must affect current judgments as to indications for the coronary bypass operation. Thus, assignment of treatment class I indicates that the bypass operation has a comparative advantage over medical treatment and suggests, but does not specifically indicate, that it has an advantage over coronary angioplasty (see Table 1 for description of treatment classes). Assignment of treatment class II indicates that the comparative benefits of the bypass operation relative to medical treatment have not yet been fully defined and suggests, but does not specifically indicate, that the same is true relative to coronary angioplasty. Assignment of treatment class III indicates that the bypass operation is generally considered not to be appropriate, specifically because of a lack of demonstrated advantage over medical treatment and, by suggestion, over coronary angioplasty.
The indications for the coronary artery bypass operation as discussed in this section are useful for background information and as guides to be modified by more patient-specific predictions and comparisons (see Section X) than were possible within the confines of this report and by clinical judgment. The adaptability of the patient to the stress and morbidity of the coronary bypass operation, and the patient's other obligations and desires, must also be considered in detail by the physician as he makes therapeutic recommendations. The patient, after learning the physician's recommendations and the risks and benefits of the procedure, should make the actual decision.
Most patients with ischemic heart disease require a number of therapeutic recommendations during the lifetime of their chronic condition, and the coronary artery bypass operation is a treatment that needs to be considered in many of these. The recommendation at any one time to use medical treatment or coronary angioplasty rather than the coronary bypass operation does not preclude the possibility that the bypass operation will be advisable at a subsequent time. B Emergency or urgent coronary bypass surgery is indicated only when intensive medical management fails to relieve the unstable angina. If the unstable state subsides within a few days of intense medical management, as is usually the case, the patient is studied further and recommendations are then made. The unstable angina syndrome predisposes a patient to recurrences of the unstable state or myocardial infarction, or both, and for this reason is a risk factor for death.31 Therefore, the indication for the coronary bypass operation (treatment class) in any of the previously described categories into which the patient may fall after study, becomes stronger when the unstable angina syndrome has recently (. 2 months) been present. When the patient's condition is good after a complication of coronary angioplasty, the indications for coronary bypass surgery are not urgent, and the treatment classes previously described apply.
7. Previous coronary bypass surgery. Evidence of return of important myocardial ischemia should be required for consideration of another coronary bypass operation in a patient who has already undergone such a procedure. Cineangiography is a requisite for decision making. If the offending disease is localized and in the native circulation or if the offending disease is in the bypassing conduits, and distal native vessels are seen to be open, another coronary bypass operation is usually indicated. When a repeat bypass operation is recommended, the indication should be strong and the patient's general health otherwise good, in view of the increased risks and uncertainties in the second operation (see Section III).
E. Theoretically Ideal Indication
Theoretically, the coronary bypass operation performed in an optimal manner at the appropriate time should have not only an appreciable comparative benefit over alternative forms of therapy but also a high event-free survival for a prolonged period (.15 years). However, a high event-free survival for . 15 years is immutably denied by important fixed (at rest) left ventricular dysfunction at the time of the coronary bypass operation, even though the greatest comparative benefit is achieved in this situation. Thus, ideally the coronary bypass operation should be performed while left ventricular function remains normal or minimally impaired. However, performing the operation under these circumstances, rather than later in the life history of patients with ischemic heart disease, is discouraged by the current limitation on the duration of the operation's favorable effect imposed by progression of the atherosclerotic disease in the native coronary arteries and in the bypassing conduits. This limitation leads to the currently appropriate tendency to defer the operation for as long as is possible, although such a strategy often results in the development of important left ventricular dysfunction at rest.
The challenge for the future is to make safe the delay of the coronary bypass operation until extensive three-vessel disease develops, by learning to predict the imminence of an acute ischemic syndrome such as myocardial infarction and resultant loss of normal left ventricular function. There are strong suggestions that alterations in the state (milieu) of the patient (instability of coronary atherosclerotic plaques,85 alterations in the thrombotic and thrombolytic mechanisms86) precede such an event, and progress is being made in identifying these alterations. 87 Once identified, the alterations may possibly be reversed by medical treatment and the infarction prevented and left ventricular function maintained. If such treatment is successful, the coronary bypass operation can then be deferred until extensive three-vessel disease develops (if it does). Cessation of cigarette smoking is a primary objective in preoperative and postoperative care. The patient should be informed of the importance of this both before and early after the operation.
The long-term treatment plan begins as soon as possible after the bypass operation, which may be as early as the third or fourth postoperative day. It consists in large part of arranging the patient's orderly transfer from the routines of in-hospital care to those in an ambulatory setting. Care is taken that administration of needed medications begun in the hospital is continued for the appropriate period after hospital discharge. The incidence of ventricular and atrial arrhythmias diminishes rapidly in the early in-hospital phase of recovery, but as many as 15% of patients may continue to experience them until the time of hospital discharge. These patients usually require only short-term (4-8 weeks) postdischarge treatment for the arrhythmia. Arrhythmias that persist after this time require special investigation.
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The patient with treated hypertension before surgery frequently does not require the use of antihypertensive agents during the early convalescence. Therefore, it is appropriate not to prescribe these agents routinely early after operation but to await a specific indication.
At the time of the early postdischarge evaluation, issues related to convalescence from the operation should be addressed with the patient and family, as well as any specific problems that may have been encountered in the hospital. Commonly, a chest roentgenogram, rest ECG, complete blood count, and a biochemical profile are obtained at that time. Thereafter, one physician should assume the responsibility for long-term management, to assure continuity of care Before the operation, an expanded explanation of the diagnostic and therapeutic procedures by the nurse can allay fears and facilitate understanding and cooperation. Nursing personnel in the areas to which the patient is transferred after the intensive care unit should be able to distinguish between minimally dangerous and potentially highly dangerous cardiac arrhythmias. They should be able to initiate resuscitative measures and recognize the indications for these. They should be knowledgeable about the postbypass surgery treatment protocols and be able to implement them skillfully. The nursing personnel should be supportive of the patient in all ways and help the patient to begin the process of convalescence.
Instruction of the patient and family by the nursing personnel, at a time when the patient is most receptive regarding risk factor modification, may favorably influence long-term outcomes. Nursing personnel assignments should be adequate to meet these goals, and well-designed programs can be cost effective.
3. Perfusionists. Trained perfusionists prepare, maintain, and operate the pump-oxygenator and related equipment during the coronary artery bypass operation and during its uncommon use before or early after cardiac surgery. They should work under the direct supervision of a physician or physicians expert in all matters relating to cardiopulmonary bypass. Nearly always this is the cardiac surgeon or cardiac anesthesiologist or, preferably, an interactive team composed of both. Working under the direction of the cardiac surgeon or anesthesiologist, or both, the perfusionist may also be responsible for the operation of red blood cell-saving procedures and circulatory assist devices.
Because the duties of perfusionists vary widely among institutions and because the perfusionist should be part of a well-coordinated physician-nursing-perfusionist team, each perfusionist should concentrate his or her practice in one hospital.
Perfusionists should be graduates of an approved perfusion technology training program or have equivalent training. 104 4. Other personnel. An active cardiac surgical program will usually require the support of a full complement of hospital professionals. These include pharmacists, dieticians, respiratory therapists, social workers, and physical therapists with cardiac rehabilitation skills.
B. Facilities 1. Cardiac operating rooms. The requisite space and equipment of an operating room for open heart surgery have been described previously. 3 The operating room should be 600-800 square feet (55-75 m2) in size, have adequate electrical grounding, oxygen and vacuum supply, proper illumination, and be capable of supporting the technical equipment utilized in cardiopulmonary bypass, including the pumpoxygenators, heat exchange equipment, cell saver, anesthetic apparatus, and assist devices.
The availability and staffing of more than one cardiac operating room per surgeon considerably enhances the efficiency and productivity of a cardiac surgical program. 2 The unit design should provide for direct visual assessment of the patients from the nursing stations. This unit should be in relatively close proximity to the operating room. Several patient areas should be large enough to accommodate multiple life support systems, such as intra-aortic balloon pumps, ventricular and total circulatory assist devices, and hemodialysis machines.
Portable chest roentgenographs should be available 24 hours a day. The unit should be able to obtain immediately arterial blood gas analyses, serum elec-trolyte measurements, and certain other laboratory tests, and should be informed of the results as soon as they are available.
Most patients undergoing an elective coronary bypass operation are able to be transferred out of the intensive care unit the morning after surgery. Early transfer reduces delays and costs and ensures optimal utilization of expensive facilities.
3. Postintensive care ("stepdown facility"). Early safe transfer from the intensive care unit is facilitated by the availability of radiotelemetry for ECG monitoring in the area to which the patient is transferred. This is preferably a standard bed area, which may have both immediately preoperative cardiac patients as well as postoperative patients. This latter group should be in the majority.
Radiotelemetry allows rapid identification of important arrhythmias. Ideally, the telemetry should be monitored 24 hours a day by technicians under the immediate direction of the nursing staff and under the overall direction of a cardiologist or cardiac surgeon. 4 . Catheterization and angiographic facility. Coronary arteriography of diagnostic quality is a requisite to the performance of coronary artery bypass surgery and must be available in any hospital with a cardiac surgery program. The optimal resources and facilities for performing cardiac catheterization and coronary angiography have been summarized previously.105'106 5 . Ambulatory pre-and postoperative care facility.
Before surgery, it may be possible to identify some preoperative low-risk patients who can be admitted to the hospital early on the morning of surgery without increased risk and with apparent institutional cost savings.107 However, it is not clear that such a strategy is advantageous to most patients or is cost-effective when all aspects of the patient care program are considered.
Early discharge of the patient from the hospital (on postoperative day 5 or 6) has been shown to be advantageous when provisions have been made for continuing close surveillance for the first 3 or 4 postdischarge days.108 This is made most effective by the availability of a well-staffed and well-equipped ambulatory patient care facility in which needed observation and tests can be performed.
C. Quality of Care
A cardiac surgery program should include regular, frequent, and formal review in conference of all deaths and major complications. This should be attended by cardiac surgeons, cardiologists, and pathologists, as well as residents and students in teaching institutions. Quality assurance programs, inservice educational programs, and multiple layers of in-house administrative reports frequently add only expense, inconvenience, and undue consumption of time to that which can be accomplished by intense, conscientious, and regular review of deaths and complications by the professional staff. In general, a yearly minimum of 100 to 150 open heart operations, the majority of which are coronary artery bypass operations, should be performed by each surgeon caring for patients with ischemic heart disease. Again, surgeons in large and sparsely populated geographic areas may require a different, specifically derived recommendation.
These recommendations about case load are general and should be applied with the knowledge that several reports attest that it is possible for a particular low volume hospital or surgical group or surgeon to have good results.1"2-1"4 3. Bases for recommendations. The issues with respect to case load are quality and appropriateness of the coronary bypass operation (at present, judged only by hospital mortality and morbidity), patient access, cost-effectiveness, and institutional morale and costs.
A. QUALITY AND APPROPRIATENESS. A relation between cardiac surgical volume and mortality after coronary bypass surgery was suggested in 1979 from comparison of outcomes between hospitals with <200 coronary bypass operations annually (5.7% mortality) and hospitals with >200 annual coronary bypass operations (3.4% mortality)."' These institutional volume effects may be even greater for emergency coronary bypass operations. '11 The most recent and thorough examinations of the relation of institutional and surgeon volume to hospital mortality are the reports from the Department of Health of the state of New York.'10''02 In that state in 1989, hospital mortality for the coronary bypass operation (n = 12,448) was 3.68%. The relation between volume (surgeon and hospital) and outcome suggests that the statewide mortality would have been 2.67% had all operations been performed by surgeons doing at least 180 cardiac operations per year in hospitals in which at least 700 cardiac operations were performed yearly ( Table 9 ).
The predicted effect of a criterion of 300 cases per year for an institution and 150 for a surgeon is in However, the variability in charges made for the coronary bypass procedure reflects both variability in actual costs and variability in the proportion of the charge that comes from overhead and related factors. This is because the charge includes 1) the actual cost of performing the procedure, 2) the overhead for supporting those hospital or professional services whose actual costs exceed the reimbursement, 3) the overhead for meeting ongoing and often unrelated costs that must be shared among users of the institution, and 4) the overhead to cover projected costs of future expansion and equipment purchases in general. The differences between charges and costs, determined by a variety of factors, must be understood in assessing the financial impact of reducing or increasing the number of cardiac procedures performed.
Additionally, any consideration of restricting the use of the coronary bypass operation in patients in whom it is indicated must take into account other results of such restrictions. Patient disability will become greater. The accumulated costs of medication, recurrent hospital stays, and subsequent myocardial infarctions and congestive heart failure will increase and may become greater than those of the coronary bypass operation.
In summary, any deliberate reduction in the number of coronary bypass procedures by rationing, in order to reduce costs, needs to consider the other fiscal, as well as human, effects of such a program.
D. Recommendations
A concerted effort should be made by the medical profession to reduce the costs of the coronary bypass operation without reducing its benefits. Since it is a commonly performed operation about which a great deal is now known, areas in which significant cost reductions can be made without sacrifice in quality should be identifiable. Unnecessary components of care relating to the coronary bypass operation should be eliminated, and one mechanism for this is the forming of appropriate guidelines and indications for the coronary bypass operation. The difficulties of accomplishing these eliminations are recognized, and include the threat to the survival of some institutions and to the livelihood of some individuals in some specialties and areas of service.
The recommendations are as follows:
1. This report has described the variables (risk factors) upon which the recommendation for one or another form of therapy can appropriately be made (Sections IV, V, VI, and X). Examinations and tests that do not relate directly to identifying the values of these variables (risk factors) should not be performed as service items, although they may be necessary in research protocols.
2. Redundancy in the provision of services within an institution should be avoided. 3 . Properly trained surgeon's assistants, rather than fully qualified surgeons, have been demonstrated to be highly competent in removing saphenous veins, opening and closing surgical incisions, acting as first assistant during CABG operations, and participating in preoperative and postoperative care under the supervision of qualified cardiothoracic surgeons. Since the length of the educational process leading to qualification as a surgeon's assistant in cardiothoracic surgery is much shorter than that leading to the MD degree and qualification as a cardiothoracic surgeon, and the overall responsibilities are less, the compensation of this group of health care workers is considerably less than that of qualified surgeons. More widespread substitution of surgeon's assistants, in both teaching and nonteaching settings, should reduce the costs related to the coronary bypass operation without reducing patient benefit and the quality of care.
4. The postoperative care of the majority of patients undergoing routine coronary artery bypass grafting is simple and straightforward. Particularly in such patients, unnecessary components of care and testing should be avoided.
5. Complications may increase costs in all these areas, and therefore before, during, and after the operation techniques and practices that reduce complications without endangering comparative benefits should be used.
X. Patient-Specific Guidelines and Indications for
the Coronary Artery Bypass Operation General information on outcome after the coronary artery bypass operation is contained in Section III, but it is not specific to any given patient because a number of risk factors determine the outcome in specific patients. Comparisons between outcome after the coronary bypass operation and noninterventional medical treatment are presented in Section IV, and comparisons between outcome after the coronary bypass operation and coronary angioplasty in Section V. These comparisons are group-specific and not specific to an individual patient and, although more helpful than simple comparisons in heterogeneous groups of patients, remain of limited value. The indications presented in Section VI are based on a limited number of risk factors, but they are not optimally useful to the physician in working with an individual patient because patients have a large number of independent risk factors, many of which could not be taken into account in the general discussion and tables in Section VI. This section describes patient-specific predictions and comparisons (see Appendix F for methodology) that are optimally useful to the physician in making recommendations to individual patients. The technique for generating patient-specific predictions and comparisons is also optimal for exploring the strength of an individual risk factor, for with it the values for all other risk factors can be held constant.
A. Background
Physicians have traditionally advised patients on the basis of the "odds of success" of alternative forms of therapy and the "risks and imponderables" associated with each. In recent years sufficient information has been obtained about outcomes that the comparative benefits and risks of the coronary bypass operation can be computed for an individual patient with his or her patient-specific risk factors.
Many physicians have not had the privilege of using computed patient-specific predictions and comparisons as a basis for recommendations to patients. Therefore, this section provides a limited number of examples, based on the equations (mathematical models) currently available for these purposes, and describes the potential future availability of techniques that simplify for physicians and institutions the making of patient-specific predictions and comparisons.
The information currently available for these purposes is limited because of several factors. The medical profession has, for the most part, not used its medical expertise to guide statisticians in the direction of analyses that would be clinically useful. Statisticians have, for the most part, preferred to use classical methods, rather than to add to them new methods more appropriate to patient care. The major randomized trials have generally not encompassed within their reports the types of analyses required for predicting and comparing for individual patients, and most of them have been unwilling even to share their data bases with others prepared to make such analyses. A notable exception is the United States Department of Veterans Affairs, which has shared with this Subcommittee certain parts of the data base (that of patients randomly assigned to initial medical treatment) from two of their randomized trials. The equations derived from these data are useful and are included in the report.
Further development of patient-specific predictions and comparisons can ultimately result not only in better but in more economic health care for patients with ischemic heart disease. These can indicate, for a specific patient at a given time, the comparative benefit and risk of noninterventional medical therapy, the coronary bypass operation, and coronary angioplasty. When sufficient information is available, predictions and comparisons can also be physician (or surgeon) specific and institution specific. The physician, using his judgment and such comparisons and predictions, can provide the patient and family with useful and reliable advice.
The bases of these patient-specific predictions and comparisons are multivariable risk factor equations, which generate not only the time-related probability of freedom from an unfavorable outcome event (and the hazard function for the event) but also the confidence intervals around the estimates. The confidence intervals quantify the degree of uncertainty in the estimate (see discussion of confidence intervals and their use in "Task Force Subcommittee Methodology" in Appendix C). The patient-specific solutions are most easily used when presented as nomograms (plots) of the survivals and hazard functions and of the comparative benefits.
Equations available for generating this information are presented in Appendix F. Because the computation of the confidence intervals is particularly complex, this is not included. The packaging of the multivariable risk factor equations and equations for computing confidence intervals on computer software suitable for use in personal computers is the best way of providing physicians and institutions with an easy-to-use capability of predicting and comparing for individual patients and groups of patients. These are available upon request from the Task Force Subcommittee.
B. Example 1 A 67-year-old man without hypertension has moderately severe stable angina (Canadian class III) and a history of a single previous myocardial infarction. His exercise test is strongly positive. He has an 80% proximal stenosis in the left anterior descending coronary artery, 30% stenosis in a large marginal branch of the circumflex artery, and a 20% stenosis in the mid-right coronary artery (right dominant system with "single-vessel disease"). His left ventricular ejection fraction is 0.55.
The benefit, with respect to survival, of initial coronary bypass surgery (and of initial coronary angioplasty) compared with that of initial medical treatment is illustrated in Figure 5 . The treatment class of the coronary bypass operation with respect to survival would be II. Example 2
A 65-year-old nonhypertensive man has moderately severe stable angina (Canadian class III) and a history of two previous myocardial infarctions. His exercise stress test is strongly positive. He has threevessel disease with an 80% proximal stenosis in his left anterior descending coronary artery, 70% stenosis in a large marginal branch of the circumflex artery, and a 75% stenosis in his mid-right coronary artery (right dominant system). His left ventricular ejection fraction is 0.40.
The comparative benefit, with respect to survival, of initial coronary bypass surgery (and of initial coronary angioplasty) compared with initial medical treatment is illustrated in Figure 6 . The treatment class of the coronary bypass operation with respect to survival would be I. 
Specific Comparisons
The patient-specific comparisons are optimal for defining the treatment class (Table 1) for the coronary bypass operation in comparison with medical treatment (or coronary angioplasty) in an individual patient. However, defining the treatment class is only one step in the process by which the physician, using all available information and his or her own best judgment, determines recommendations to the patient.
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Treatment class I can be considered to apply to situations (patients) in which there is 1) a computed time-related greater probability of freedom from important unfavorable events such as death after the coronary bypass operation than after initial medical treatment (or after coronary angioplasty), and the 70% confidence intervals of the freedom after the coronary bypass operation are widely separated from those after other treatments, and 2) the 90% confidence intervals of the comparative benefit of the coronary bypass operation do not touch or overlap zero benefit for that period of time. Currently, this prescribed degree of certainty of the comparative benefit of the coronary bypass operation can be reached only when the comparative benefit is considerable. When more data from larger groups of patients become available, the confidence intervals should become more narrow and the prescribed degree of certainty may be reached when the comparative benefit of the bypass operation is small. Then an arbitrary definition may be required as to the magnitude of the comparative benefit that would make the coronary bypass operation indicated and advisable.
Treatment class II applies to situations (patients) in which there is 1) a computed time-related greater probability of freedom after the coronary bypass operation than after medical treatment (or coronary angioplasty), but the 70% confidence intervals of the freedom after the bypass operation touch or overlap for a considerable part of the time with those of medical treatment, and 2) the 90% confidence intervals of the comparative benefit include (overlap with) zero benefit for a considerable period of time.
Treatment class III applies to situations (patients) in which there is no computed time-related comparative benefit of the coronary bypass operation over medical treatment. (The rationale for these definitions are in "Task Force Subcommittee Methodology" in Appendix C).
Similar treatment classes should soon be definable for the coronary bypass operation in comparison with coronary angioplasty or any other form of treatment.
XI. Bases for Health Care Policy Concerning the Coronary Artery Bypass Operation Private and public health care policy concerning patients with ischemic heart disease should have as part of its bases appropriate time-related information concerning unfavorable outcome events after alternative forms of treatment. Whereas Section X relates primarily to individual patients, this section relates primarily to groups of patients. This section discusses A) appropriateness of the coronary bypass operation, B) quality of care, and C) cumulative years of freedom from an unfavorable event.
Health care policy must of course consider costs as well, and this matter has been discussed briefly in Section IX. Detailed consideration of cost of the coronary bypass operation in relation to benefit and health care policy is beyond the scope of this report.
A. Appropriateness of the Coronary Bypass Operation Widespread inappropriate use of the coronary bypass operation or of coronary angioplasty would be economically wasteful as well as disadvantageous to the individual patient. However, the definition of inappropriateness (and, conversely, of appropriateness) has not been accomplished with any unanimity of opinion. Therefore, many studies of these matters have resorted to consensus opinion, derived in one manner or another. All such studies are seriously flawed by the biases, stated or unstated, of each member of the panel of experts, and by the bias underlying the selection of the members of the panel. At present, enough information about the coronary artery bypass operation exists, as summarized in this report, that the seeking of consensus opinion is no longer necessary.
Appropriateness of a procedure is generally sought retrospectively. In this regard, it is similar to quality of care, discussed in the next part of this section.
Appropriateness of a procedure, such as the coronary bypass operation, should be assessed on the basis of the time-related results of the procedure. Appropriateness is analogous to the indications for the operation, except that the indications are sought prospectively, before the procedure. Thus the methodology for determining the patient-specific indications for a procedure (see Section X) also applies to determining appropriateness.
An interventional procedure can be considered to have been appropriate (as compared with medical treatment) for an individual patient when its treatment class is I (as defined by patient-specific criteria in part C of Section X). The appropriateness of a procedure that, for an individual patient, is in treatment class II is uncertain, and it should be decided administratively. Comparative costs should probably be considered. New procedures will often fall into treatment class II, because of the small numbers of patients for analysis with resultant wide confidence intervals and the relatively short period of follow-up. Therefore, new and promising procedures in treatment class II may be considered appropriate for a few years. A procedure can be considered inappropriate when its treatment class is III.
The same procedure can be used to evaluate the appropriateness of one type of interventional procedure (such as coronary angioplasty) in comparison with that of another (such as the coronary bypass operation).
B. Quality of Care
Quality of care in the case of the coronary bypass operation is currently judged on the basis of hospital mortality. An assessment of quality of care on this basis has been done in an exemplary manner by the Department of Health of the state of New York.
There, Hannan and colleagues6'1617 have developed a reporting system from each of the 30 hospitals in the state performing cardiac surgery, and that system has provided data for multivariable analysis and identification of the incremental risk factors for hospital death in their population of patients. With use of the derived risk factor equation, an expected hospital mortality with its 95% confidence intervals was computed for each hospital in the state. The expected hospital mortality was defined as the mortality to be expected had that hospital's specific patients, with their patient-specific risk factors, been operated on, so to speak, by the state of New York as a whole. Hospitals whose actual mortality rate was above the 95% confidence intervals of the expected mortality rate could be considered to be failing to deliver care of good quality. With further refinements, these techniques were used to rank the hospitals in the state according to quality of care as judged by risk-adjusted hospital mortality.
Ideally, morbidity and length of hospital stay, as well as mortality, should be computed and compared in a similar risk-adjusted manner and considered in an overall evaluation of quality of care in the case of the coronary bypass operation. The physical and emotional comfort of the patients and family also require consideration in this regard.
In the quest for a low hospital mortality rate, it must always be remembered that the coronary bypass operation may, in the best of hands, currently have a relatively high hospital mortality in certain types of cases and still have for these cases a large and near-certain comparative benefit (appropriateness) when compared with alternative forms of treatment.
C. Cumulative Years of Freedom From an Unfavorable Event
Most physicians and patients think in terms of and use the time-related probability of freedom from alternative forms of therapy. Life insurance actuaries and government often use the cumulative years of freedom from an unfavorable event, also termed the percent retention ofpotential time offreedom from an unfavorable event. This latter criterion is appropriate when the goal is preservation of total years of life of a skilled work force or the calculation of costs in terms of preservation of the maximal number of years of life or consideration of the resources necessary to pay pensions and annuities of a given population. The important point is that a different answer is obtained depending on the criteria used, and failure to understand this could create confusion and lead to unnecessary conflict.
An example is presented in Figures 7 and 8 . In Figure 7 , the information is depicted in the form used throughout this ACC/AHA Task Force Subcommittee Report, with the time-related probability of survival after coronary bypass and after initial medical treatment depicted on the left side and the hazard function on the right. With use of the derived equations, the probabilities have been extended to 16 years, in order to see clearly the time when they cross. The "crossing point" is at a different interval after starting treatment in the survival plot (10.7 years) compared with the hazard function (6.6 years).
In Figure 8 , the same information is presented in terms of the percent retention of potential lifetime (freedom from death). [126] [127] [128] In this criterion, the survival curves after the coronary bypass operation and that after initial medical treatment cross twice, and the last crossing is at 16.1 years.
These three different times, at which the curves come together and then cross, result from three different criteria or methods of presenting the information.
Appendix A The Coronaty Artery Bypass Graft Operation (Section II) 168 48 Medical Benefit Figure D1 ). In the upper left was depicted the time-related probability of freedom from the event after the coronary artery bypass operation, for example, and that after an alternative form of treatment, such as initial medical treatment (or coronary angioplasty). In the lower left was presented the comparative benefit, or the time-related difference in the probability of freedom after the two therapies, "+" resulting from a greater freedom after the coronary bypass operation and indicating a comparative benefit in favor of the operation and "-C" resulting from a lesser freedom after the operation and indicating a comparative benefit in favor of the alternative form of treatment. In the upper right was presented timerelated hazard functions for the unfavorable outcome event after the two forms of therapy. In the lower right was presented the time-related hazard ratio, depicting again the benefit from the operation or lack thereof. Here no difference was indicated by "1," a benefit from the operation by a ratio < 1, and benefit from the alternative form of therapy by a ratio >1. (In many figures in the report, such as Figure C4 , the hazard functions and hazard ratio were not included because of limitations of space.) Typically, in the two upper depictions the 70% confidence intervals around the continuous point estimates of freedom after each of the two treatment strategies were shown. Seventy percent confidence intervals (rather than the wider 95% confidence intervals) were used because of the unreasonableness in clinical medicine of concluding "no benefit" primarily because of a fairly small number of patients in a study. This could happen were the criteria to be nonoverlapping 95% confidence intervals (or a p value <0.05). In the two lower depictions, the "O" and "1" had no confidence intervals, so the lines of comparative benefit were surrounded by their 90% confidence intervals.
When the 70% confidence intervals of the timerelated probabilities of freedom for each of the two treatments were widely separated, a p value .0.05 was assured, and the inference was that a "near certain difference" existed. When the 70% intervals nearly but not quite touched, a p value .0.10 was likely, and the inference was that a "probable difference" existed. These two situations have been classified as treatment class I (Table 1) . When the 70% _r~~~~~~~~~~~~~~~~~~~~~~~~~~~~.
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-- (table) under 'Angina III-IVJ ") a) Survival in patients with no proximal stenosis. b) Format similar to a, except that one proximal stenosis was present. c) Format similar to a, except that two proximal stenoses were present. d) Format similar to a, except that three proximal stenoses were present. Note the gradually decreasing survival with initial medical treatment in these four graphs and the consequent progressive increase in surgical benefit. Survival after coronary bypass surgery is similar in the four groups, indicating that the bypass operation has neutralized the incremental risk of the proximal stenoses.
which the continuous point estimate and confidence intervals of both the probability of freedom and the hazard function could be generated.24 This was begun by converting the usual life-table depiction of the publication into the cumulative hazard function domain. (When an original data set is being analyzed parametrically, the first informal estimate of the number of hazard phases is made in this domain.) A three-phase hazard function was initially assumed to be present (a reasonable assumption from many previous analyses of alternative forms of treatment, including medical treatment, for ischemic heart disease). Then the data were tested for their fit to this assumption. If indicated by this fitting, one or more phases were deleted. Then the data were expressed in an equation, using the techniques of the parametric method in the hazard function domain. 24 In the Subcommittee depictions, the actuarial estimates from the paper were also depicted, to provide a validation of the parametric estimate.
The confidence intervals from the usual variancecovariance matrix in the parametric method are mainly dependent on the total number of events occurring during the period of study. The raw data necessary for the computation of the variance-covariance matrix were not in the publications from the literature. However, the total number of events was usually stated or could be calculated. The confidence intervals were therefore estimated using this number, recognizing that this was only the best possible estimate under the circumstances.
This method has been validated by comparing the Subcommittee depiction of the time-related probability of survival, with its confidence intervals, after randomly assigned initial medical treatment in the Veterans Administration trial (as seen in Figure 7 2. On thallium scintigraphy: a) reversible thallium defects in more than one area at risk, or in a very large single area; b) increased thallium uptake by the lungs during exercise (reflecting pulmonary edema). analyses have found stenoses .50% to be risk factors for an unfavorable outcome event.) An exception is the left main coronary artery, in which a .50% reduction in luminal diameter is considered to be an important stenosis.
The phrases one-vessel, two-vessel, or three-vessel coronary artery disease consider as "a vessel" the left anterior descending coronary artery, the right coronary artery, or the posterior descending coronary artery, and the left circumflex coronary artery and/or one or more large marginal branches. The circulation should always be labeled "right dominant," "left dominant," or "co-dominant," according to the origin of the posterior descending coronary artery.
E. Left Ventricular Dysfunction
For the purposes of this report, left ventricular dysfunction at rest has been termed "absent, grade 0,', or "present, and mild, moderate, or severe in degree" on the basis of ejection fraction or Coronary Artery Surgery Study (CASS) score (Table El) The methodology for patient-specific predicting and comparing is simple, and in essence has been described in Section X and alluded to in other parts of the report. The bases of the methodology are multivariable risk factor equations, preferably in the hazard function domain.
The equations currently available for patientspecific predicting and comparing, along with coefficients and p values, are depicted on the following pages. The confidence intervals are determined by the variance-covariance matrix, which is more complex than can conveniently be printed. The equations and the variance-covariance matrix (for confidence intervals) are available as computer software from the Subcommittee. These can be used in a personal computer for generating patient-specific predictions and comparisons.
The Subcommittee deeply appreciates the privilege of using the multivariable risk factor equations in the hazard function domain for probability of freedom from unfavorable outcome events after the coronary bypass operation, derived in collaboration with and from the data base of Dr There is a tendency to believe that the confidence intervals are wider when predicting time-related probability of freedom from an unfavorable outcome event for an individual than when predicting it for a group. To some extent this is based on a misunderstanding of what is being predicted, and to some extent it reflects the fact that this matter remains one of opinion and not one of proof. It is the opinion of the Subcommittee, on the basis of expert statistical advice, that the width of the confidence intervals when predicting time-related probability (a parameter estimate) for an individual is the same as when predicting for a group. (The details of the logic and statistical and mathematical bases for this belief are available from the Subcommittee on request.)
The Equations
The form of the risk factor equations is the loglinear one. 24 The definitions and units of variables appearing more than once in a set of equations are in all instances the same as in their initial use.
1. Multivariable tisk factor equation for death after the coronary bypass operation (UAB, 1977 (UAB, -1981 
